Procarbazine and Lomustine in Recurrent Glioblastoma
Condition(s):Recurrent Glioblastoma MultiformeLast Updated:December 3, 2012Unknown status
Hide Studies Not Open or Pending
Condition(s):Recurrent Glioblastoma MultiformeLast Updated:December 3, 2012Unknown status
Condition(s):Brain and Central Nervous System TumorsLast Updated:February 22, 2012Withdrawn
Condition(s):Advanced Hodgkin’s LymphomaLast Updated:September 4, 2018Unknown status
Condition(s):LymphomaLast Updated:July 30, 2012Unknown status
Condition(s):Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4Last Updated:July 26, 2011Unknown status
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 21, 2013Completed
Condition(s):CNS Lymphoma; CNS Brain Cancer; Non-Hodgkin’s LymphomaLast Updated:February 8, 2023Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:September 9, 2021Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:September 11, 2012Completed
Condition(s):Chemotherapeutic Agent Toxicity; Cognitive/Functional Effects; Lymphoma; Neurotoxicity; Radiation ToxicityLast Updated:July 20, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.